A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

OBJECTIVES: To assess the efficacy and tolerability of cabazitaxel in relapsed penile cancer. METHODS: This Phase II single-arm trial was designed to recruit 17 patients with relapsed penile cancer. The primary endpoint was objective (complete + partial) response rate (ORR; Response Evaluation Crite...

Descripción completa

Detalles Bibliográficos
Autores principales: Challapalli, Amarnath, Pearson, Sylvia, Mitra, Anita V., Coe, Marc, Thomson, Alastair, Elliott, Tony, Kirkbride, Peter, Pickering, Lisa, Kirk, Hannah, Foulstone, Emily, Evans, Heidi, Bravo, Alicia, Bahl, Amit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833416/
https://www.ncbi.nlm.nih.gov/pubmed/31502503
http://dx.doi.org/10.1177/0300060519863546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833416/
https://www.ncbi.nlm.nih.gov/pubmed/31502503
http://dx.doi.org/10.1177/0300060519863546

Ejemplares similares